Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Ruxolitinib can help regrow hair in severe alopecia areata.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Espumil foam base allows easy preparation of skin medications for hairy areas.

Ritlecitinib can help about 14,000 people with severe hair loss.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Anti-TNF therapy can cause hair loss and skin issues.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Tofacitinib treatment for hair loss may worsen acne.

Clofazimine effectively treated a rare skin condition with ash-gray patches.

A patient's allergic reaction to clozapine resolved without stopping the medication, showing the importance of blood monitoring.

Azathioprine can cause unusual hair loss, which may reverse after stopping the drug.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

Mesalazine may help treat extensive alopecia areata effectively.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Removing UBE2N from skin cells causes inflammation and immune response, which can be lessened with specific inhibitors.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

Cetirizine may help treat hair loss safely by reducing scalp inflammation.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.